ArticleStatistics in medicine2020
Design for immuno-oncology clinical trials enrolling both responders and nonresponders.
Zhenzhen Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it